• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物敏感和多药耐药的人卵巢癌细胞中的细胞质膜胆固醇与阿霉素细胞毒性

Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.

作者信息

Mazzoni A, Trave F

机构信息

Department of Pharmacology, Chemotherapy and Toxicology, University of Milan School of Medicine, Italy.

出版信息

Oncol Res. 1993;5(2):75-82.

PMID:8364256
Abstract

The possible involvement of cholesterol (CHOL) in the cellular transformations leading to the acquisition of the multidrug-resistance (MDR) phenotype has been evaluated in human ovarian cancer cells. To this end, the A2780 cell line and the 52-fold doxorubicin (DX)-resistant counterpart A2780-DX3 were analyzed under two different growth conditions: standard culture medium (FCS medium), or medium deprived of CHOL (LPDS medium). The following variables were investigated: free and esterified cytoplasmic membrane CHOL, cell growth, DX uptake and cytotoxicity, and low-density lipoprotein uptake and degradation (as indirect variables of CHOL homeostasis). The impact of the calcium antagonist verapamil (VER) on these variables was assessed. The results obtained indicate that under standard growth conditions, A2780 and A2780-DX3 cells are different not only with respect to DX uptake and sensitivity, but also with respect to membrane CHOL content and the ratio of free-to-esterified CHOL. The deprivation of lipoproteins in the culture medium, apart from slowing cell growth, induced a decrease in the cytoplasmic membrane CHOL content (mainly of the esterified form) that was particularly evident in A2780 sensitive cells. In LPDS medium, a reduced DX uptake occurred in both cell lines, but to a greater extent in A2780 cells, in which DX cytotoxicity decreased to values comparable to that of A2780-DX3 resistant cells. Restoration of DX sensitivity was achieved with the addition of 10 microM VER.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在人卵巢癌细胞中,已对胆固醇(CHOL)在导致多药耐药(MDR)表型获得的细胞转化过程中的可能作用进行了评估。为此,在两种不同的生长条件下分析了A2780细胞系和对阿霉素(DX)耐药52倍的对应细胞系A2780-DX3:标准培养基(FCS培养基)或不含CHOL的培养基(LPDS培养基)。研究了以下变量:游离和酯化的细胞质膜CHOL、细胞生长、DX摄取和细胞毒性,以及低密度脂蛋白摄取和降解(作为CHOL稳态的间接变量)。评估了钙拮抗剂维拉帕米(VER)对这些变量的影响。所得结果表明,在标准生长条件下,A2780和A2780-DX3细胞不仅在DX摄取和敏感性方面存在差异,而且在膜CHOL含量以及游离CHOL与酯化CHOL的比例方面也存在差异。培养基中脂蛋白的缺乏,除了减缓细胞生长外,还导致细胞质膜CHOL含量(主要是酯化形式)降低,这在A2780敏感细胞中尤为明显。在LPDS培养基中,两种细胞系的DX摄取均减少,但在A2780细胞中减少程度更大,其中DX细胞毒性降至与A2780-DX3耐药细胞相当的值。添加10 microM VER可恢复DX敏感性。(摘要截短于250字)

相似文献

1
Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.药物敏感和多药耐药的人卵巢癌细胞中的细胞质膜胆固醇与阿霉素细胞毒性
Oncol Res. 1993;5(2):75-82.
2
Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.
Anticancer Res. 1991 Nov-Dec;11(6):2181-5.
3
Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells.噻帕米类似物RO11 - 2933对敏感及多药耐药的人卵巢癌细胞对抗肿瘤药物细胞敏感性的影响。
Anticancer Res. 1989 Mar-Apr;9(2):367-71.
4
Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.重组人肿瘤坏死因子逆转人卵巢癌细胞系A2780-DX3中的“非典型”多药耐药性
Oncol Res. 1993;5(8):311-23.
5
The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.拓扑替康在延长复发性卵巢癌无铂间期方面的作用:体外模型
Gynecol Oncol. 2004 Jul;94(1):67-73. doi: 10.1016/j.ygyno.2004.03.047.
6
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.耐药性人卵巢肿瘤细胞系对肿瘤坏死因子(TNF-α)与阿霉素联合作用的敏感性:联合用药未能调节多药耐药表型
Gynecol Oncol. 1993 Feb;48(2):214-20. doi: 10.1006/gyno.1993.1036.
7
[Establishment of adriamycin-resistant human ovarian carcinoma cell line and its mechanism of multidrug resistance].
Yao Xue Xue Bao. 1995;30(4):258-62.
8
Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
Cell Mol Biol (Noisy-le-grand). 1993 Jul;39(5):543-51.
9
Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.新型鏻盐对人卵巢癌细胞系显示出体外和体内细胞毒性活性。
Gynecol Oncol. 1996 Feb;60(2):203-12. doi: 10.1006/gyno.1996.0026.
10
Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.多药耐药性MCF - 7细胞对转铁蛋白 - 阿霉素偶联物的敏感性
Anticancer Res. 1994 Mar-Apr;14(2A):397-403.

引用本文的文献

1
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.负载高活性阿霉素衍生物的固体脂质纳米粒的研制与表征
Nanomaterials (Basel). 2018 Feb 16;8(2):110. doi: 10.3390/nano8020110.
2
Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.膜活性宿主防御肽——新型抗癌药物开发的挑战与展望。
Chem Phys Lipids. 2011 Nov;164(8):766-81. doi: 10.1016/j.chemphyslip.2011.09.004. Epub 2011 Sep 16.
3
Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids.
乳腺癌细胞的耐药性:细胞膜脂与阿霉素相互作用的生物物理特性研究。
Mol Pharm. 2010 Dec 6;7(6):2334-48. doi: 10.1021/mp100308n. Epub 2010 Nov 11.
4
Lipid rafts: dream or reality for cholesterol transporters?脂筏:胆固醇转运蛋白的梦想还是现实?
Eur Biophys J. 2007 Nov;36(8):869-85. doi: 10.1007/s00249-007-0193-8. Epub 2007 Jun 19.
5
Rafts as missing link between multidrug resistance and sphingolipid metabolism.筏作为多药耐药性与鞘脂代谢之间的缺失环节。
J Membr Biol. 2005 Jan;203(2):57-64. doi: 10.1007/s00232-004-0733-4.
6
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.亚氨基二苄基和吩噻嗪的喹诺里西啶基衍生物作为卵巢癌细胞中的多药耐药调节剂
Invest New Drugs. 2003 Nov;21(4):413-20. doi: 10.1023/a:1026295017158.
7
Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences.多药耐药癌细胞中脂筏和小窝的脂质和蛋白质成分变化及其功能后果。
Glycoconj J. 2000 Mar-Apr;17(3 -4):253-9. doi: 10.1023/a:1026553626537.
8
Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells.多药耐药癌细胞中膜微区和小窝成分的变化。
Lipids. 1999;34 Suppl:S57-63. doi: 10.1007/BF02562229.
9
Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.表达典型多药耐药表型的肿瘤细胞的生化、遗传和代谢适应性。新疗法的逆转作用。
J Bioenerg Biomembr. 1997 Aug;29(4):401-13. doi: 10.1023/a:1022459100409.
10
Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.一些双性两亲性药物的膜相互作用及其与多药耐药逆转能力的关系。
J Cancer Res Clin Oncol. 1996;122(1):27-40. doi: 10.1007/BF01203070.